Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Resmed Inc

RMD ✓ COMPLIANT ☆ Track — members

NYSE · Healthcare · Advanced Medical Equipment & Technology ·

USA Large Cap Analyst: HOLD

Last Close

$224.46

▼ -1.01%

Market Cap $32.38B · Vol 411.98K

Key Metrics

P/E Ratio

21.51

FWD: 18.36

Market Cap

$32.38B

Large Cap

Div Yield

1.16%

Quarterly dividend

EPS Growth

+8.24%

YoY

RSI (14)

67.36

Momentum

Beta

0.76

vs Market

52W High

$293.81

23.60% below

52W Low

$180.41

24.42% above

Volume

411.98K

Avg 422.89K

P/B

4.27

Price-to-book

ROE

26.00%

Return on equity

Free Float

99.50%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Resmed Inc (RMD) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does RMD pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+5.91%

+16.29%

+10.87%

-11.12%

YTD

-6.81%

-21.16%

+22.42%

-18.41%

Financials & Valuation

TTM · Annual

Total Revenue	$5.65B
Net Income	$1.52B
Revenue Growth (YoY)	+8.58%
Gross Margin	60.25%
Operating Margin	33.96%
Net Profit Margin	26.94%
ROE	26.00%
ROA · ROIC	22.40% · 21.95%

P/E Ratio	21.51
Forward P/E (FY1)	18.36
PEG Ratio	1.92
P/S	5.03
P/B	4.27
P/FCF	17.48
EPS Growth	+8.24%
Outstanding Shares	144.25M

Technical Indicators

50-Day SMA	$203.80
200-Day SMA	$229.77
RSI (14)	67.36
Beta	0.76
52-Week High	$293.81
52-Week Low	$180.41

Volume Today	411.98K
Avg Daily Volume (30D)	422.89K
Relative Volume	0.97x
Volatility (10D)	38.93
Volatility (30D)	41.48
Free Float	99.50%

Analyst Consensus

HOLD

Current Price $224.46

Mean Target $246.92

52W Low$180.41 52W High$293.81

Current

Target

$180.41 $293.81

Current Analyst target

+10.01% upside potential · 21 analysts

Identifiers

ExchangeNYSE

FIGIBBG001SBGRC2

ISINUS7611521078

CountryUnited States of America

Sub-IndustryAdvanced Medical Equipment & Technology (NEC)

Earnings DateOct 28, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

TMO Thermo Fisher Scientific Inc -1.28% DHR Danaher Corp -0.71% ISRG Intuitive Surgical Inc -1.68% BSX Boston Scientific Corp +0.27% EW Edwards Lifesciences Corp -1.04%

Company Profile

ResMed Inc. is a holding company. The Company, through its subsidiaries, in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Its segments include Sleep and Breathing Health segment and the Residential Care Software segment. It also operates a Software as a Service (SaaS) business in the United States and Germany that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. Its products and solutions are designed to improve patients' quality of life and reduce the impact of chronic disease. Its cloud-based digital health software applications, along with its devices, are designed to provide connected care.